Compare Danaher Corporation (DHR) vs First Citizens BancShares Inc (FCNCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs First Citizens BancShares Inc — how do they compare? Danaher Corporation trades at $219.87 (market cap $152.87B), while First Citizens BancShares Inc trades at $2,068.39 (market cap $22.94B). The key difference: Danaher Corporation is far larger — about 6.7× First Citizens BancShares Inc's market cap, and Danaher Corporation pays the higher dividend (0.74%). Which is the better fit depends on your goals — on Pluang, investors hold Danaher Corporation for 69 Days and First Citizens BancShares Inc for 29 Days on average.
| DHR | FCNCA | |
|---|---|---|
Market Cap | $152.87B | $22.94B |
Volume | 5,228,698 | 91,668 |
Sector | Health | Sector/Thematic |
52-Week High | $242.05 | $2.29K |
52-Week Low | $161.91 | $1.64K |
Typical Hold Time | 69 Days | 29 Days |
Enterprise Value | $175.08B | — |
Dividend Yield | 0.74% | 0.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $217.46, down 0.47% on the day, with a bullish technical signal from moving averages and support at $214. The company shows strong profitability with a 58.51% gross margin and has beaten EPS estimates for three consecutive quarters. Recent news includes a declared $0.40 dividend payable in October 2026 and significant institutional buying, such as Bank of America's new $993.8 million stake in Q2 2026.
The outlook is positive with a consensus price target of $230.31, implying 5.9% upside, supported by 70% analyst buy ratings. Risks include elevated valuation multiples like a P/E of 38.76 and fluctuating cash flows, but earnings growth in biotechnology and steady revenue provide a solid foundation for investor confidence.
First Citizens BancShares (FCNCA) trades at $2,068.39, down slightly by 0.15% with a bearish technical signal. The company demonstrates strong fundamentals with a P/E of 11.08 and net income margin of 25.23%, having beaten earnings estimates for three consecutive quarters. Recent business developments include branch acquisitions and new financing initiatives, while analyst consensus shows 82% hold ratings with a $2,290 price target.
FCNCA presents a mixed outlook with strong profitability metrics offset by bearish technical indicators. Investment opportunity lies in continued earnings outperformance and strategic expansion, while risks include negative cash flow trends and institutional selling pressure. The stock offers value characteristics but requires monitoring of technical support levels near $2,028.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →
